Suchergebnisse - "Myeloma"

PubPharm (311)

1

Role of Aiolos and Ikaros in the Antitumor and Immunomodulatory Activity of IMiDs in Multiple Myeloma : Better to Lose Than to Find Them

enthalten in: International journal of molecular sciences | 2021

von Cippitelli, M. | Stabile, H. | Kosta, A. | +4

2

DNA methylation inhibition in myeloma : Experience from a phase 1b study of low-dose continuous azacitidine in combination with lenalidomide and low-dose dexamethasone in relapsed or refractory multiple myeloma

enthalten in: Seminars in hematology | 2021

von Khouri, J. | Faiman, B. | Grabowski, D. | +21

3

Role of Aiolos and Ikaros in the Antitumor and Immunomodulatory Activity of IMiDs in Multiple Myeloma: Better to Lose Than to Find Them

in: International Journal of Molecular Sciences | 2021

von Marco Cippitelli | Helena Stabile | Andrea Kosta | +4

4

Adherence to Lenalidomide in Older Adults With Newly Diagnosed Multiple Myeloma

enthalten in: Clinical lymphoma, myeloma & leukemia | 2020

von Mian, H. | Fiala, M. | Wildes, T.

5

雷利度胺加干扰素联合改良MP方案治疗老年多发性骨髓瘤血象变化分析 : = A Clinical Research on Hemogram Variation in Patients with Multiple Myeloma Treated with and Interferon in Combination with MP Regimen

enthalten in: Shi jie zui xin yi xue xin xi wen zhai | 2019-01-18

China Academic Journals (CAJ), E, 医药卫生科技 = Medicine & Public Health

von 刘庆荣 | 李伟 | 胡建威 | +2

6

Lenalidomide versus lenalidomide + dexamethasone prolonged treatment after second-line lenalidomide + dexamethasone induction in multiple myeloma

enthalten in: Cancer medicine | 2018

von Lund, J. | Gruber, A. | Lauri, B. | +17

7

Improvement in overall survival with carfilzomib, lenalidomide, and dexamethasone in patients with relapsed or refractory multiple myeloma

enthalten in: Journal of clinical oncology | January 17, 2018

von Siegel, D. | Dimopoulos, M. | Ludwig, H. | +7

8

CD138 Negative Plasma Cells in Relapsed CNS Multiple Myeloma

enthalten in: Indian journal of hematology & blood transfusion | 2017

von Singh, N. | Gandhi, J. | Agrawal, N. | +3

9

Population Pharmacokinetic Analysis of Ixazomib, an Oral Proteasome Inhibitor, Including Data from the Phase III TOURMALINE-MM1 Study to Inform Labelling

enthalten in: Clinical pharmacokinetics | 2017

von Gupta, N. | Diderichsen, P. | Hanley, M. | +4

10

Pharmacokinetics of Daratumumab Following Intravenous Infusion in Relapsed or Refractory Multiple Myeloma After Prior Proteasome Inhibitor and Immunomodulatory Drug Treatment

enthalten in: Clinical pharmacokinetics | 2017

von Clemens, P. | Yan, X. | Lokhorst, H. | +9

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[32]